• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异手性蛋白质-蛋白质相互作用的精确从头设计。

Accurate de novo design of heterochiral protein-protein interactions.

作者信息

Sun Ke, Li Sicong, Zheng Bowen, Zhu Yanlei, Wang Tongyue, Liang Mingfu, Yao Yue, Zhang Kairan, Zhang Jizhong, Li Hongyong, Han Dongyang, Zheng Jishen, Coventry Brian, Cao Longxing, Baker David, Liu Lei, Lu Peilong

机构信息

College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.

Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.

出版信息

Cell Res. 2024 Dec;34(12):846-858. doi: 10.1038/s41422-024-01014-2. Epub 2024 Aug 14.

DOI:10.1038/s41422-024-01014-2
PMID:39143121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11614891/
Abstract

Abiotic D-proteins that selectively bind to natural L-proteins have gained significant biotechnological interest. However, the underlying structural principles governing such heterochiral protein-protein interactions remain largely unknown. In this study, we present the de novo design of D-proteins consisting of 50-65 residues, aiming to target specific surface regions of L-proteins or L-peptides. Our designer D-protein binders exhibit nanomolar affinity toward an artificial L-peptide, as well as two naturally occurring proteins of therapeutic significance: the D5 domain of human tropomyosin receptor kinase A (TrkA) and human interleukin-6 (IL-6). Notably, these D-protein binders demonstrate high enantiomeric specificity and target specificity. In cell-based experiments, designer D-protein binders effectively inhibited the downstream signaling of TrkA and IL-6 with high potency. Moreover, these binders exhibited remarkable thermal stability and resistance to protease degradation. Crystal structure of the designed heterochiral D-protein-L-peptide complex, obtained at a resolution of 2.0 Å, closely resembled the design model, indicating that the computational method employed is highly accurate. Furthermore, the crystal structure provides valuable information regarding the interactions between helical L-peptides and D-proteins, particularly elucidating a novel mode of heterochiral helix-helix interactions. Leveraging the design of D-proteins specifically targeting L-peptides or L-proteins opens up avenues for systematic exploration of the mirror-image protein universe, paving the way for a diverse range of applications.

摘要

能够选择性结合天然L-蛋白的非生物D-蛋白已引起了重大的生物技术关注。然而,支配这种异手性蛋白质-蛋白质相互作用的潜在结构原理在很大程度上仍然未知。在本研究中,我们展示了由50-65个残基组成的D-蛋白的从头设计,旨在靶向L-蛋白或L-肽的特定表面区域。我们设计的D-蛋白结合剂对一种人工L-肽以及两种具有治疗意义的天然存在的蛋白质表现出纳摩尔亲和力:人原肌球蛋白受体激酶A(TrkA)的D5结构域和人白细胞介素-6(IL-6)。值得注意的是,这些D-蛋白结合剂表现出高对映体特异性和靶标特异性。在基于细胞的实验中,设计的D-蛋白结合剂以高效力有效抑制了TrkA和IL-6的下游信号传导。此外,这些结合剂表现出显著的热稳定性和对蛋白酶降解的抗性。以2.0 Å分辨率获得的设计的异手性D-蛋白-L-肽复合物的晶体结构与设计模型非常相似,表明所采用的计算方法高度准确。此外,晶体结构提供了有关螺旋L-肽与D-蛋白之间相互作用的有价值信息,特别是阐明了一种新型的异手性螺旋-螺旋相互作用模式。利用专门针对L-肽或L-蛋白的D-蛋白设计为系统探索镜像蛋白质世界开辟了道路,为广泛的应用铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/973d6e38773f/41422_2024_1014_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/d9f674a76eb7/41422_2024_1014_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/6c7f616df600/41422_2024_1014_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/3cbcd00d15f9/41422_2024_1014_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/232018e15490/41422_2024_1014_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/dfaba6e4f479/41422_2024_1014_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/973d6e38773f/41422_2024_1014_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/d9f674a76eb7/41422_2024_1014_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/6c7f616df600/41422_2024_1014_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/3cbcd00d15f9/41422_2024_1014_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/232018e15490/41422_2024_1014_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/dfaba6e4f479/41422_2024_1014_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c6a/11614891/973d6e38773f/41422_2024_1014_Fig6_HTML.jpg

相似文献

1
Accurate de novo design of heterochiral protein-protein interactions.异手性蛋白质-蛋白质相互作用的精确从头设计。
Cell Res. 2024 Dec;34(12):846-858. doi: 10.1038/s41422-024-01014-2. Epub 2024 Aug 14.
2
Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase.靶向致癌性BCR::ABL1激酶的镜像单链抗体的研发。
Nat Commun. 2024 Dec 23;15(1):10724. doi: 10.1038/s41467-024-54901-y.
3
Computational design of heterochiral peptides against a helical target.针对螺旋靶点的异手性肽的计算设计。
J Am Chem Soc. 2006 Jan 25;128(3):809-16. doi: 10.1021/ja054452t.
4
Has AlphaFold 3 Solved the Protein Folding Problem for D-Peptides?AlphaFold 3解决了D-肽的蛋白质折叠问题吗?
bioRxiv. 2025 Mar 17:2025.03.14.643307. doi: 10.1101/2025.03.14.643307.
5
An study of protein-protein interactions and design of novel peptides for TrkA in ameloblastoma.成釉细胞瘤中TrkA的蛋白质-蛋白质相互作用及新型肽设计的研究
J Biomol Struct Dyn. 2024;42(24):13768-13778. doi: 10.1080/07391102.2023.2278083. Epub 2023 Nov 17.
6
Pyrrolinone-based peptidomimetics. "Let the enzyme or receptor be the judge".基于吡咯烷酮的肽模拟物。“让酶或受体来评判”。
Acc Chem Res. 2011 Mar 15;44(3):180-93. doi: 10.1021/ar1001186. Epub 2010 Dec 22.
7
Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.新型拮抗性抗TrkA单克隆抗体MNAC13对NGF-TrkA受体相互作用的中和作用:结构洞察
Proteins. 2005 Feb 15;58(3):717-27. doi: 10.1002/prot.20366.
8
Rational design and chemical modification of TEAD coactivator peptides to target hippo signaling pathway against gastrointestinal cancers.通过合理设计和化学修饰 TEAD 共激活肽来靶向 hippo 信号通路以对抗胃肠道癌症。
J Recept Signal Transduct Res. 2021 Aug;41(4):408-415. doi: 10.1080/10799893.2020.1818093. Epub 2020 Sep 10.
9
Designing Coiled Coils for Heterochiral Complexation to Enhance Binding and Enzymatic Stability.设计螺旋线圈以实现异手性络合,增强结合和酶稳定性。
Biomacromolecules. 2024 Aug 12;25(8):5273-5280. doi: 10.1021/acs.biomac.4c00661. Epub 2024 Jul 9.
10
Design of Cyclic Peptide Binders Based on Fragment Docking and Assembling.基于片段对接与组装的环肽结合剂设计
J Chem Inf Model. 2025 Apr 28;65(8):4206-4218. doi: 10.1021/acs.jcim.5c00088. Epub 2025 Apr 14.

引用本文的文献

1
Effect of glycosylation on protein folding: From biological roles to chemical protein synthesis.糖基化对蛋白质折叠的影响:从生物学作用到化学蛋白质合成
iScience. 2025 May 8;28(6):112605. doi: 10.1016/j.isci.2025.112605. eCollection 2025 Jun 20.
2
Advances in the chemical synthesis of human proteoforms.人类蛋白质异构体化学合成的进展。
Sci China Life Sci. 2025 Apr 8. doi: 10.1007/s11427-024-2860-5.
3
Stereochemistry in the disorder-order continuum of protein interactions.蛋白质相互作用无序-有序连续统中的立体化学

本文引用的文献

1
Mirror-image T7 transcription of chirally inverted ribosomal and functional RNAs.手性反转核糖体和功能 RNA 的镜像 T7 转录。
Science. 2022 Oct 28;378(6618):405-412. doi: 10.1126/science.abm0646. Epub 2022 Oct 27.
2
Design of protein-binding proteins from the target structure alone.从目标结构设计蛋白质结合蛋白。
Nature. 2022 May;605(7910):551-560. doi: 10.1038/s41586-022-04654-9. Epub 2022 Mar 24.
3
Computational Design of Potent D-Peptide Inhibitors of SARS-CoV-2.计算设计强效 D-肽抑制剂抑制 SARS-CoV-2。
Nature. 2024 Dec;636(8043):762-768. doi: 10.1038/s41586-024-08271-6. Epub 2024 Nov 27.
J Med Chem. 2021 Oct 28;64(20):14955-14967. doi: 10.1021/acs.jmedchem.1c00655. Epub 2021 Oct 8.
4
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
5
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites.锚定延伸:一种设计靶向酶活性位点的环状肽的结构导向方法。
Nat Commun. 2021 Jun 7;12(1):3384. doi: 10.1038/s41467-021-23609-8.
6
Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1.基于计算设计的新型德里金属β-内酰胺酶 1 的环肽抑制剂。
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12). doi: 10.1073/pnas.2012800118.
7
A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth.一种无免疫原性的二价 d 蛋白可有效抑制视网膜血管生成和肿瘤生长。
ACS Chem Biol. 2021 Mar 19;16(3):548-556. doi: 10.1021/acschembio.1c00017. Epub 2021 Feb 23.
8
Trends in peptide drug discovery.肽类药物研发趋势。
Nat Rev Drug Discov. 2021 Apr;20(4):309-325. doi: 10.1038/s41573-020-00135-8. Epub 2021 Feb 3.
9
Computational design of mixed chirality peptide macrocycles with internal symmetry.具有内对称的混合手性肽大环的计算设计。
Protein Sci. 2020 Dec;29(12):2433-2445. doi: 10.1002/pro.3974.
10
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.从头设计皮摩尔级 SARS-CoV-2 小蛋白抑制剂。
Science. 2020 Oct 23;370(6515):426-431. doi: 10.1126/science.abd9909. Epub 2020 Sep 9.